Sudden Sensorineural Hearing Loss: Results of intratympanic steroids as salvage treatment [PDF]
, 2013 Objective: The aim of the present study was to verify the efficacy and the safety of intratympanic dexamethasone to treat sudden sensorineural hearing loss as salvage therapy. Materials and methods: A prospective study was conducted on patients affected
COSTANTINO, Claudio +4 more
core +1 more source
Intratympanic membrane cholesteatoma after traumatic tympanic membrane perforation: a case report
Journal of Medical Case Reports, 2023 Background Intratympanic membrane cholesteatoma presents as an asymptomatic, white, round mass on the tympanic membrane, and is usually detected incidentally in children.
Junhui Jeong, Hyun Seung Choi
doaj +1 more source
Intratympanic gentamicin treatment for Ménière's disease: A randomized, double-blind, placebo-controlled trial on dose efficacy - results of a prematurely ended study [PDF]
, 2014 Background: Gentamicin is used as a therapeutic agent for Ménière's disease because of its vestibulotoxicity causing chemo-ablation of the vestibular sensory epithelia. Its use has increased in recent years. However, there is still no consensus about the
Bremer, H.G. (Hendrik G.) +9 more
core +3 more sources
Effect of Intratympanic Dexamethasone in Idiopathic Sudden Sensorineural Hearing Loss
Bengal Journal of Otolaryngology and Head Neck Surgery, 2019 Introduction Oral steroids currently represent the standard treatment for idiopathic sudden sensorineural hearing loss The aim of this study is to assess the effectiveness of intratympanic dexamethasone injection for treating ‘Idiopathic sudden ...
Rabi Hembrom +4 more
doaj +3 more sources
Audiology Research, 2012 The purpose of this study is to test the effectiveness of intratympanic dexamethasone injections as a treatment for severe tinnitus in idiopathic sudden sensorineural hearing loss (SNHL).
Tadao Yoshida +4 more
doaj +1 more source
Intratympanic Steroid Treatment in Méniére Disease [PDF]
, 2017 Méniére disease (MD) is characterized by vertigo attacks, hearing loss, tinnitus, and aural fullness. Although the exact treatment of MD is lacking, several treatment options including conservative, medical, and surgical aim to control symptoms. Recently,
Aksoy, Sinan +6 more
core +2 more sources
Intratympanic Steroids in Severe to Profound Sudden Sensorineural Hearing Loss as Salvage Treatment [PDF]
, 2010 ObjectivesIntratympanic steroids are being increasingly used in the treatment of sudden sensorineural hearing loss (SSNHL) after the failure of systemic therapy.
Lee, Byung Don +4 more
core +3 more sources
Local Delivery of Therapeutics to the Inner Ear: The State of the Science
Frontiers in Cellular Neuroscience, 2019 Background: Advances in the understanding of the genetic and molecular etiologies of inner ear disorders have enabled the identification of therapeutic targets and innovative delivery approaches to the inner ear.
Caroline R. Anderson +11 more
doaj +1 more source
In vitro and in vivo effects of lutein against cisplatin-induced ototoxicity [PDF]
, 2016 This is peer reviewed version of the following article Experimental and Toxicologic Pathology 68.4 (2016): 197-204, which has been published in final form at http://dx.doi.org/10.1016/j.etp.2016.01.003Introduction: Cisplatin is a commonly prescribed ...
García-Berrocal, J. R. +6 more
core +2 more sources
Intratympanic dexamethasone for managing pregnant women with sudden hearing loss
Journal of International Medical Research, 2019 Objective This study aimed to investigate the effect and safety of intratympanic dexamethasone in pregnant women with idiopathic sudden sensorineural hearing loss (ISSNHL).
Yaoyao Fu +3 more
doaj +1 more source